Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Pneumococcal polysaccharide vaccine
Filetype[PDF-324.39 KB]


Details:
  • Supporting Files:
    No Additional Files
    1. Yellow fever vaccine : what you need to know
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      3/30/2011
      Series:
      Vaccine information statement
      Description:
      Yellow fever is a serious disease caused by the yellowfever virus. It is found in certain parts of Africa andSouth America.Yellow fever is spread through the bite of an infected mosquito. It cannot be spread person to person by direct contact.
      File Type:
      Filetype[PDF - 320.12 KB]
    2. Serogroup B meningococcal vaccine (MenB ): what you need to know
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      08/09/2016
      Series:
      Vaccine information statement
      Description:
      mening-serogroup.pdf
      File Type:
      Filetype[PDF - 297.50 KB]
You May Also Like:
  1. Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease.
    Personal Author:
    Fiore, A. E.; Levine, O. S.; Elliott, J. A.; Facklam, R. R.; Butler, J. C.;
    Published Date:
    1999 Nov-Dec
    Source:
    Emerg Infect Dis. 5(6):828-831.
    Description:
    To estimate the effectiveness of pneumococcal polysaccharide vaccine, we serotyped isolates submitted to the Pneumococcal Sentinel Surveillance System from 1984 to 1996 from 48 vaccinated and 125 unvaccinated children 2 to 5 years of age. Effectivene...
    File Type:
    Filetype[PDF - 94.74 KB]
  2. Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Breiman, Robert F.; Butler, Jay C.; Nuorti, J. Pekka;
    Corporate Authors:
    Centers for Disease Control (U.S.). Immunization Practices Advisory Committee.. Centers for Disease Control and Prevention (U.S.). National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases..
    Published Date:
    April 4, 1997
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 46, no. RR-8
    Description:
    " This report updates the last recommendations by the Advisory Committee on Immunization Practices (ACIP) concerning pneumococcal polysaccharide vaccine (MMWR 1989;38:64-8,73-6). ACIP recommends that the vaccine be used more extensively and administe...
    Status:
    superseded
    File Type:
    Filetype[PDF - 287.30 KB]
  3. New vaccines for the prevention of pneumococcal infections.
    Personal Author:
    Käyhty, H.; Eskola, J.;
    Published Date:
    1996 Oct-Dec
    Source:
    Emerg Infect Dis. 2(4):289-298.
    Description:
    Streptococcus pneumoniae is a major cause of acute otitis media, pneumonia, bacteremia, and meningitis. Because in recent years antibiotic-resistant pneumococcal strains have been emerging throughout the world, vaccination against pneumococcal infect...
    File Type:
    Filetype[PDF - 68.34 KB]
  4. Pneumococcal Prevention Gets Older and Wiser
    Personal Author:
    Schuchat, Anne
    Published Date:
    Dec 2015
    Source:
    JAMA Intern Med. 175(12):1897-1898.
    File Type:
    Filetype[PDF - 38.13 KB]
  5. Pneumococcal disease and pneumococcal vaccines
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division.
    Published Date:
    8/27/15
    Series:
    Pink book webinar series
    Epidemiology and prevention of vaccine preventable diseases webinar series
    Description:
    Originally aired on August 26, 2015.Course Number EC2064Publication date from document properties.EPV8.pdf
    File Type:
    Filetype[PDF - 853.45 KB]